Galecto, Inc. (DMRA) vs Janux Therapeutics, Inc. (JANX)
- Galecto, Inc. DMRA 18.42 −1.71%
- Janux Therapeutics, Inc. JANX 16.49 −4.79%
Galecto, Inc. and Janux Therapeutics, Inc. are both Biotechnology companies. Galecto, Inc. and Janux Therapeutics, Inc. are of similar size ($1.2B and $1.1B). Galecto, Inc. has the higher net margin (0.00% vs −427.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Galecto, Inc. leads on 6 and Janux Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | DMRA | JANX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (598.15%) | 0.00% |
| Net margin | 0.00% | (427.47%) | 0.00% |
| Free cash flow margin | 0.00% | (174.69%) | 0.00% |
| Return on equity | (26.26%) | (10.70%) | (56.36%) |
| Return on assets | (18.64%) | (10.06%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack